Categories
World News

AMC inventory quadruples as retail traders raid hedge-fund brief targets

Street performers in Minnie Mouse costumes walk past an AMC movie theater in New York’s Times Square at night on October 15, 2020.

Amir Hamja | Bloomberg | Getty Images

Shares in contested cinema giant AMC Entertainment more than quadrupled at the opening bell on Wednesday, amid a spate of trading activity in some of Wall Street’s worst-shortened stocks.

Approximately 10 minutes after the session began, trading in stocks ceased for the first time due to volatility. The stocks were stopped several times during the first hour of trading when there was heavy activity.

At 3 p.m. on Wall Street, it was trading 265% higher at $ 18.06. Previously, it rose up to 310% immediately after the shares opened. During premarket trading, stocks were up as much as 360%.

About an hour after trading, more than 500 million shares had already changed hands – well above the average 30-day volume of the share of 86.8 million shares per day. More than 1 billion shares had been traded by 3 p.m. CET.

Individual investors create brief bottlenecks by piling up in these names, while hedge funds, on the other hand, in short supply, cover their losses quickly. They promote their activities on the Wallstreetbets Reddit Board, which has 2.8 million members. AMC appeared to be a growing topic on the board.

Short selling is a strategy in which investors borrow shares of a stock at a certain price in the expectation that the market value will drop below that level when it is time to pay for the borrowed shares.

Retail investor influence – most notably in GameStop – has drawn the streets under its spell for the past few days, appealing to a new class of traders who grew up amid the pandemic. GameStop stock more than doubled on Wednesday, up 110%.

“The limelight has moved from Large Cap Tech / Retail Favorites to a largely ignored corner of severely shortened small cap stocks,” Barclays said in a statement to clients on Tuesday. “Within a month, retail has made a significant impact on the price and sentiment in these heavily truncated names, cementing investor dominance of retail options.”

TD Ameritrade announced on Wednesday lunchtime that certain transactions with GameStop and AMC Entertainment have been restricted “in the interests of reducing the risk to our company and our customers”.

AMC has pegged 24% of its float to short rates, and GameStop’s short rate is 138%, according to FactSet.

AMC rose 26% on Monday and 12% on Tuesday and is up more than 370% this week. On Monday, the company announced it had received enough funding to stay open and operational through 2021.

“This means that any talk of an impending bankruptcy for AMC is completely off the table,” said CEO Adam Aron.

During the month, AMC stocks are up more than 650%. Given the stock’s downtrend over the past few years, lower profit is now responsible for a much larger percentage move.

The passion spread to some other heavily shortened names in early trading. Bed Bath & Beyond jumped more than 35%. According to data from S3 Partners, the retailer is the second most-trimmed stock on the market. 64% of its float is sold short. Eastman Kodak, another speculative name, was up 16%. The short interest in this stock is around 20%.

Amid the surge in AMC Entertainment, AMC Networks stocks were also in motion. The stock rose as much as 22% before returning those gains. Shares recently fell 7%.

Short interest is the number of stocks that are being sold short relative to a company’s total available stock of stocks.

Categories
Health

President Joe Biden targets 1.5 million Covid vaccinations a day, up from 1 million

President Joe Biden makes remarks before signing a “Made in America” ​​executive order on January 25, 2021 in the Auditorium of the South Court at the White House in Washington, DC.

Jim Watson | AFP | Getty Images

President Joe Biden said Monday the United States could hit 1.5 million Covid-19 vaccinations per day, surpassing its previously targeted pace of 1 million per day, which the Trump administration has already neared.

Biden has pledged to give 100 million shots of coronavirus vaccine in his first 100 days in office, which equates to a rate of 1 million shots a day.

“That is my promise that we will get 100 million vaccinations,” he said on Monday. “I think if the grace of God and the goodwill of the neighbor and the fools don’t rise as the old saying goes, we can maybe bring that to 1.5 million a day instead of 1 million a day, but we have to target that of a million a day. “

Some public health professionals criticized Biden’s promise to give 100 million vaccine shots in his first 100 days in office as being too modest. By the time Biden took over the presidency last week, the US was well on its way to the necessary pace of 1 million shots a day. According to the Centers for Disease Control and Prevention, the US exceeded an average of 1.1 million vaccinations per day for seven days on Sunday.

And with the expected launch of Johnson & Johnson’s one-shot vaccine next month, the Biden administration is now saying the pace of 1 million shots a day is more of a floor than a target. The two currently approved vaccines from Pfizer and Moderna require two doses to achieve maximum protection against the virus. The potential approval of JNJ’s one-time vaccine could significantly accelerate the mass effort.

But just last week, Biden rejected the idea that the goal of 100 million vaccinations in 100 days might be too low a threshold, claiming he was told before he took office that the target might be too high.

“I find it fascinating that yesterday the press asked, ‘Is 100 million enough?’ The week before they said, “Biden, are you crazy? You can’t make 100 million in 100 days, “said the President on Friday.” God willing, we will not just do 100 million, we will do more than that. “

Biden said Monday that the administration is working to increase the number of people who administer the shots, increase production of the cans, and create more facilities where people can schedule appointments and get their vaccinations.

“Time is of the essence,” he said. “We are trying to get at least 100 million vaccinations in 100 days and move in the next 100 days where we are way beyond that to get to the point where we can get herd immunity in a country.” of over 300 million people. “

His change of tune reflects comments made by White House Chief Medical Officer Dr. Anthony Fauci, who served in the Trump administration, handed in this weekend. Fauci said Sunday that Biden’s goal of 100 million doses in 100 days was not a final number.

“It’s really a floor, not a ceiling,” Fauci told CBS’s Face The Nation program. “It’s going to be a challenge. I think it was a sensible goal that was set. We always want to do better than the goal you set.”

With a limited dose offer, states are still rationing life-saving recordings and setting a wide variety of approval parameters. The Trump administration, and now the White House in Biden, have encouraged both states to quickly move through the eligibility stages in an attempt to expand the population able to receive the vaccines.

Biden said Monday from a reporter when the US will get to the point where anyone who wants to get the vaccines will be able to, Biden said this spring. But he added it would be “a logistical challenge that surpasses anything we’ve ever tried in this country.”

“I am confident that by the summer we will be well on the way to achieving herd immunity,” he said.

But even when Biden voiced a more aggressive target for the vaccination campaign, he added Monday that the US “will see between 600,000 and 660,000 deaths before we start turning the corner in the right direction”.

And the president painted an even gloomier picture last week, saying, “There is nothing we can do to change the course of the pandemic over the next few months.”

– CNBC’s Nate Rattner contributed to this report.

Categories
Health

Peter Thiel-backed psychedelics start-up ATAI targets schizophrenia

LONDON – ATAI Life Science, a Peter Thiel-backed start-up, has acquired a majority stake in Recognify, a company that develops drugs to treat schizophrenia.

ATAI is headquartered in Berlin and aims to manufacture psychedelics that can be used to treat mental disorders. Recognify, meanwhile, is specifically aiming to create a drug that can be used to treat the cognitive impairment associated with schizophrenia, or CIAS.

The latter company was co-founded by the German-American biochemist Thomas Sudhof, who received a Nobel Prize in Physiology or Medicine in 2013.

The terms of the deal were not disclosed, but ATAI said it was in the “tens of millions”.

ATAI, calling itself a drug development platform, was formed to acquire, incubate, and develop psychedelics and other drugs that can be used to treat depression, anxiety, addiction, and other mental illnesses. In return for a controlling stake in the drugs they develop, ATAI helps scientists raise money, work with regulators, and conduct clinical trials.

Treatment of schizophrenia

Recognify’s lead drug, RL-007, has been tested in nine clinical studies on 508 people, including rats, according to ATAI. Clinical trial results were not published.

Srinivas Rao, co-founder and chief scientist of ATAI, told CNBC through Zoom that Recognify has developed a “very interesting” compound that has been shown to have benefits.

“Things like verbal memory and things like that were actually greatly enhanced with this connection,” said Rao. “And that’s something that is deficient in patients with schizophrenia. So that’s really the requirement here. We want to extend the results that exist now to the schizophrenic population.”

Schizophrenia affects around 20 million people, according to the World Health Organization, which results in people hearing voices and seeing things that are not real through hallucinations, and can also cause disorganized and confused thinking.

IPO plans

The news of the Recognify deal comes after ATAI raised $ 125 million from investors like Thiel in November, ahead of a listing this year. The total investment in the company is now over $ 210 million.

“The great virtue of ATAI is taking mental illness as seriously as we should have,” said Thiel, co-founder of Palantir and PayPal, in a statement shared with CNBC at the time. “The company’s most valuable asset is its urgency.”

The two-year company, which has offices in Berlin, New York and San Diego, currently works with around 10 drug development companies.

According to an industry source who wanted to remain anonymous due to the nature of the discussions, there are plans to launch ATAI with a value between $ 1 billion and $ 2 billion in the next few months.

Categories
Politics

Feds Order States to Increase Vaccine Targets as Covid-19 Deaths Surge

The Centers for Disease Control and Prevention last month recommended that states vaccinate, after vaccinating health workers and residents of long-term care facilities, people over 75 and certain “frontline workers” who cannot do their jobs from home should. Only then, the CDC advised, should states turn to people ages 65 to 74 and adults of all ages with high-risk diseases. The CDC recommendations were not binding, but many states have largely followed them while demand far outstrips supply.

How Mr Azar’s enforcement threat will work is unclear. In two weeks, Mr. Biden will have been sworn in as President. Mr Azar said the upcoming Biden administration will be informed of the changes, although he added that Americans “are working with a government at a time and this is the approach we believe will best serve the mission.”

Mr Biden is expected to release details of his own vaccination schedule this week, which will include federal government-sponsored mass vaccination clinics. The Biden transition team declined to comment on the new Trump policy on Tuesday. However, a person familiar with the president-elect’s plans said Mr Biden also had plans to expand the universe of those eligible for vaccination.

Mr Azar said that people searching for gunfire because they are at high risk of disease are required to provide “some form of medical documentation as defined by the governors,” but he did not elaborate. A significant portion of the population suffers from conditions that the CDC has determined to increase the risk of serious Covid disease, starting with obesity, which affects at least 40 percent of adults.

Other people who would qualify for vaccines immediately under Mr Azar’s policy are more than 30 million adults with heart disease, 37 million with chronic kidney disease and 1 in 10 with diabetes.

The new distribution plan, first announced by Axios Tuesday morning, is a reversal for the Trump administration, which had withheld about half of its vaccine supplies – millions of vials – to ensure second doses were available. Mr Azar said the administration always expected to make the move if they were convinced of the supply chain.

Dr. Paul Offit, a professor at the University of Pennsylvania and a member of the Food and Drug Administration’s Vaccine Advisory Board, praised the government’s decision and compared the current situation to the Titanic, where there weren’t enough lifeboats to save everyone. “And you have to decide who you want to pass on. “